User profiles for Perceval Sondag

Perceval Sondag

Merck
Verified email at merck.com
Cited by 156

[HTML][HTML] Calibration curves in quantitative ligand binding assays: recommendations and best practices for preparation, design, and editing of calibration curves

…, S MacMannis, A Safavi, J Sailstad, P Sondag - The AAPS journal, 2018 - Springer
The accuracy of reported sample results is contingent upon the quality of the assay calibration
curve, and as such, calibration curves are critical components of ligand binding and other …

Analytical procedure validation and the quality by design paradigm

E Rozet, P Lebrun, JF Michiels, P Sondag… - Journal of …, 2015 - Taylor & Francis
Since the adoption of the ICH Q8 document concerning the development of pharmaceutical
processes following a quality by design (QbD) approach, there have been many discussions …

[HTML][HTML] Quality controls in ligand binding assays: recommendations and best practices for preparation, qualification, maintenance of lot to lot consistency, and …

M Azadeh, P Sondag, Y Wang, M Raines, J Sailstad - The AAPS journal, 2019 - Springer
Quality controls (QCs) are the primary indices of assay performance and an important tool in
assay lifecycle management. Inclusion of QCs in the testing process allows for the detection …

Evaluation of performance, acceptance, and compliance of an auto-injector in healthy and rheumatoid arthritic subjects measured by a motion capture system

…, W Li, C Clawson, D Karvani, P Sondag… - Patient preference …, 2018 - Taylor & Francis
Purpose The study aimed to develop a motion capture system that can track, visualize, and
analyze the entire performance of self-injection with the auto-injector. Methods Each of nine …

The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA‐BIOP Nonclinical Bayesian …

P Faya, P Sondag, S Novick, D Banton… - Pharmaceutical …, 2021 - Wiley Online Library
The use of Bayesian methods to support pharmaceutical product development has grown in
recent years. In clinical statistics, the drive to provide faster access for patients to medical …

Quality by design applied in formulation development and robustness

P Lebrun, P Sondag, X Lories, JF Michiels… - Statistics for …, 2018 - taylorfrancis.com
Optimizing a formulation buffer for biological products such as vaccines or monoclonal
antibodies is a complex task. One of the reasons for this is that the number of formulation …

Comparisons of outlier tests for potency bioassays

P Sondag, L Zeng, B Yu, H Yang… - Pharmaceutical …, 2020 - Wiley Online Library
Potency bioassays are used to measure biological activity. Consequently, potency is considered
a critical quality attribute in manufacturing. Relative potency is measured by comparing …

Effect of a statistical outlier in potency bioassays

P Sondag, L Zeng, B Yu, R Rousseau… - Pharmaceutical …, 2018 - Wiley Online Library
The USP<1032> guidelines recommend the screening of bioassay data for outliers prior to
performing a relative potency (RP) analysis. The guidelines, however, do not offer advice on …

Assay validation

P Sondag, P Lebrun, E Rozet, B Boulanger - Nonclinical Statistics for …, 2016 - Springer
Recently, the lifecycle management concept for analytical procedures was introduced. It is
strongly related to the Quality by Design concept given in the ICH-Q8 guidance. This contrasts …

Comment and completion: implementation of parallelism testing for four-parameter logistic model in bioassays

P Sondag, R Joie, H Yang - PDA journal of pharmaceutical science …, 2015 - journal.pda.org
Parallelism testing between two four-parameter logistic curves has been widely discussed
over the last decade. Current tests available in common statistical software used in …